Viewing Study NCT07103668


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-01-01 @ 6:56 PM
Study NCT ID: NCT07103668
Status: RECRUITING
Last Update Posted: 2025-10-23
First Post: 2025-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module